On 25 May 2011 the European Directive 2009/136/EC, regarding ePrivacy and the use of cookies on websites, entered into force. The use of cookies is essential for our site, such as our shipping tools and services and in order for these to be used cookies have been set. You may delete or block all cookies from this site, but not all parts of the site will work.

Bioniche Pharma

Bioniche Pharma

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology and dermatology. The company's growth is fueled by an internal development pipeline and an aggressive acquisition strategy for products. Bioniche Pharma was acquired in September 2010 by Mylan Inc. (Nasdaq; MYL), a Fortune 500 company that ranks as one of the world's leading generic and specialty pharmaceuticals companies, providing products to customers in more than 140 countries and territories. Mylan's acquisition of Bioniche Pharma provides the company with immediate entry into the North American injectables market and a platform for the commercialization of future biosimilar product offerings.

We ship Worldwide
PayPal Logo